Pfizer maternal RSV vaccine gets FDA approval By: MarketWatch August 21, 2023 at 17:54 PM EDT New shot designed to protect babies against leading cause of hospitalization is expected to be available this fall. Read More >> Related Stocks: Astrazeneca Plc ADR Gsk Plc ADR Moderna Inc Pfizer Sanofi-Aventis S.A. ADR
